IBDEI15N ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20381,1,4,0)
 ;;=4^Lymphoma Nec Unspec Site
 ;;^UTILITY(U,$J,358.3,20381,1,5,0)
 ;;=5^202.80
 ;;^UTILITY(U,$J,358.3,20381,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,20382,0)
 ;;=782.2^^107^1257^33
 ;;^UTILITY(U,$J,358.3,20382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20382,1,4,0)
 ;;=4^Local Suprficial Swellng
 ;;^UTILITY(U,$J,358.3,20382,1,5,0)
 ;;=5^782.2
 ;;^UTILITY(U,$J,358.3,20382,2)
 ;;=^71690
 ;;^UTILITY(U,$J,358.3,20383,0)
 ;;=401.9^^107^1257^13
 ;;^UTILITY(U,$J,358.3,20383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20383,1,4,0)
 ;;=4^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,20383,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,20383,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,20384,0)
 ;;=355.9^^107^1257^12
 ;;^UTILITY(U,$J,358.3,20384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20384,1,4,0)
 ;;=4^Mononeuritis NOS
 ;;^UTILITY(U,$J,358.3,20384,1,5,0)
 ;;=5^355.9
 ;;^UTILITY(U,$J,358.3,20384,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,20385,0)
 ;;=171.9^^107^1257^2
 ;;^UTILITY(U,$J,358.3,20385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20385,1,4,0)
 ;;=4^Mal Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,20385,1,5,0)
 ;;=5^171.9
 ;;^UTILITY(U,$J,358.3,20385,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,20386,0)
 ;;=117.9^^107^1257^1
 ;;^UTILITY(U,$J,358.3,20386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20386,1,4,0)
 ;;=4^Mycoses NOS
 ;;^UTILITY(U,$J,358.3,20386,1,5,0)
 ;;=5^117.9
 ;;^UTILITY(U,$J,358.3,20386,2)
 ;;=^87308
 ;;^UTILITY(U,$J,358.3,20387,0)
 ;;=415.19^^107^1257^14
 ;;^UTILITY(U,$J,358.3,20387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20387,1,4,0)
 ;;=4^Pulm Emb & Infarc NEC
 ;;^UTILITY(U,$J,358.3,20387,1,5,0)
 ;;=5^415.19
 ;;^UTILITY(U,$J,358.3,20387,2)
 ;;=^303285
 ;;^UTILITY(U,$J,358.3,20388,0)
 ;;=780.60^^107^1257^29
 ;;^UTILITY(U,$J,358.3,20388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20388,1,4,0)
 ;;=4^Fever NOS
 ;;^UTILITY(U,$J,358.3,20388,1,5,0)
 ;;=5^780.60
 ;;^UTILITY(U,$J,358.3,20388,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,20389,0)
 ;;=787.20^^107^1257^58
 ;;^UTILITY(U,$J,358.3,20389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20389,1,4,0)
 ;;=4^Dysphagia NOS
 ;;^UTILITY(U,$J,358.3,20389,1,5,0)
 ;;=5^787.20
 ;;^UTILITY(U,$J,358.3,20389,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,20390,0)
 ;;=786.30^^107^1257^45
 ;;^UTILITY(U,$J,358.3,20390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20390,1,4,0)
 ;;=4^Hemoptysis NOS
 ;;^UTILITY(U,$J,358.3,20390,1,5,0)
 ;;=5^786.30
 ;;^UTILITY(U,$J,358.3,20390,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,20391,0)
 ;;=787.60^^107^1257^62
 ;;^UTILITY(U,$J,358.3,20391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20391,1,4,0)
 ;;=4^Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,20391,1,5,0)
 ;;=5^787.60
 ;;^UTILITY(U,$J,358.3,20391,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,20392,0)
 ;;=294.20^^107^1257^10
 ;;^UTILITY(U,$J,358.3,20392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20392,1,4,0)
 ;;=4^Dementia NOS
 ;;^UTILITY(U,$J,358.3,20392,1,5,0)
 ;;=5^294.20
 ;;^UTILITY(U,$J,358.3,20392,2)
 ;;=^340607
 ;;^UTILITY(U,$J,358.3,20393,0)
 ;;=435.2^^107^1257^15
 ;;^UTILITY(U,$J,358.3,20393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20393,1,4,0)
 ;;=4^Subclavian Steal Syndrome
 ;;^UTILITY(U,$J,358.3,20393,1,5,0)
 ;;=5^435.2
 ;;^UTILITY(U,$J,358.3,20393,2)
 ;;=^115012
 ;;^UTILITY(U,$J,358.3,20394,0)
 ;;=435.8^^107^1257^16
 ;;^UTILITY(U,$J,358.3,20394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20394,1,4,0)
 ;;=4^Trans Cereb Ischemia
 ;;^UTILITY(U,$J,358.3,20394,1,5,0)
 ;;=5^435.8
 ;;^UTILITY(U,$J,358.3,20394,2)
 ;;=^269752
 ;;
 ;;$END ROU IBDEI15N
